Safety and feasibility of chemoembolization with doxorubicin-loaded small Calibrated microspheres in patients with hepatocellular carcinoma: results of the MIRACLE I prospective multicenter study

PurposeThe MIRACLE I pilot study was designed as a preliminary investigation of safety and efficacy of Embozene TANDEM microspheres loaded with doxorubicin for treatment of locally untreatable (i.e., unresectable and not suitable for local thermal ablation) hepatocellular carcinoma (HCC).Materials a...

Full description

Saved in:
Bibliographic Details
Main Authors: Richter, Götz Martin (Author) , Radeleff, Boris (Author) , Stroszczynski, Christian (Author) , Pereira, Philippe L. (Author) , Helmberger, Thomas (Author) , Barakat, Mark (Author) , Huppert, Peter E. (Author)
Format: Article (Journal)
Language:English
Published: 2018
In: CardioVascular and interventional radiology
Year: 2018, Volume: 41, Issue: 4, Pages: 587-593
ISSN:1432-086X
DOI:10.1007/s00270-017-1839-2
Online Access:Verlag, Volltext: http://dx.doi.org/10.1007/s00270-017-1839-2
Verlag, Volltext: https://link.springer.com/article/10.1007/s00270-017-1839-2
Get full text
Author Notes:Götz Richter, Boris Radeleff, Christian Stroszczynski, Philippe Pereira, Thomas Helmberger, Mark Barakat, Peter Huppert

MARC

LEADER 00000caa a2200000 c 4500
001 1575844621
003 DE-627
005 20230427042917.0
007 cr uuu---uuuuu
008 180530s2018 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00270-017-1839-2  |2 doi 
035 |a (DE-627)1575844621 
035 |a (DE-576)505844621 
035 |a (DE-599)BSZ505844621 
035 |a (OCoLC)1341010374 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Richter, Götz Martin  |e VerfasserIn  |0 (DE-588)1068606568  |0 (DE-627)820513555  |0 (DE-576)427924057  |4 aut 
245 1 0 |a Safety and feasibility of chemoembolization with doxorubicin-loaded small Calibrated microspheres in patients with hepatocellular carcinoma  |b results of the MIRACLE I prospective multicenter study  |c Götz Richter, Boris Radeleff, Christian Stroszczynski, Philippe Pereira, Thomas Helmberger, Mark Barakat, Peter Huppert 
264 1 |c 2018 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First Online: 22 November 2017 
500 |a Gesehen am 30.05.2018 
520 |a PurposeThe MIRACLE I pilot study was designed as a preliminary investigation of safety and efficacy of Embozene TANDEM microspheres loaded with doxorubicin for treatment of locally untreatable (i.e., unresectable and not suitable for local thermal ablation) hepatocellular carcinoma (HCC).Materials and MethodsPatients with locally untreatable HCC (mono- or bilobar disease, ECOG performance status 0-2, Child-Pugh score < 11) were eligible for this single-arm multicenter study. DEB-TACE was performed with 75 µm Embozene TANDEM loaded with 150 mg of doxorubicin.ResultsTwenty-five subjects with 41 tumors were treated (mean age 65 years); 16, 52, and 32% had BCLC A, B, and C status, respectively. Child-Pugh status was A for 64%, B for 32%, and C for 4%; 40% had ascites. About 92% had disease localized to one liver lobe. Most (72%) underwent ≤ 2 DEB-TACE procedures. Average doxorubicin dose was 124.5 ± 36.1 mg (median 150 mg) per procedure. Two patients had procedure-related SAE (liver necrosis, worsening of liver insufficiency) within 30 days of the first DEB-TACE procedure. Six-month freedom from procedure-related SAE or death was 68% (one hepatic encephalopathy, five deaths). Tumor response or stable disease was achieved in 95% (20/21) of subjects. Freedom from tumor progression or death at 6 months was 76%. The one-year survival rate was 56% overall and 73% among patients without ascites at baseline.ConclusionMIRACLE I results suggest that Embozene TANDEM microspheres loaded with doxorubicin can provide good local tumor control in a heterogeneous group of patients with locally untreatable HCC.Level of EvidenceLevel 2b, Individual cohort study. 
700 1 |a Radeleff, Boris  |d 1969-  |e VerfasserIn  |0 (DE-588)123910846  |0 (DE-627)706470826  |0 (DE-576)293938504  |4 aut 
700 1 |a Stroszczynski, Christian  |e VerfasserIn  |0 (DE-588)113112076  |0 (DE-627)519851021  |0 (DE-576)289752329  |4 aut 
700 1 |a Pereira, Philippe L.  |e VerfasserIn  |0 (DE-588)1096341069  |0 (DE-627)856711411  |0 (DE-576)467988013  |4 aut 
700 1 |a Helmberger, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Barakat, Mark  |e VerfasserIn  |4 aut 
700 1 |a Huppert, Peter E.  |e VerfasserIn  |0 (DE-588)1155192338  |0 (DE-627)1016526997  |0 (DE-576)501463410  |4 aut 
773 0 8 |i Enthalten in  |t CardioVascular and interventional radiology  |d Berlin : Springer, 1978  |g 41(2018), 4, Seite 587-593  |h Online-Ressource  |w (DE-627)253390451  |w (DE-600)1458490-6  |w (DE-576)072283483  |x 1432-086X  |7 nnas  |a Safety and feasibility of chemoembolization with doxorubicin-loaded small Calibrated microspheres in patients with hepatocellular carcinoma results of the MIRACLE I prospective multicenter study 
773 1 8 |g volume:41  |g year:2018  |g number:4  |g pages:587-593  |g extent:7  |a Safety and feasibility of chemoembolization with doxorubicin-loaded small Calibrated microspheres in patients with hepatocellular carcinoma results of the MIRACLE I prospective multicenter study 
856 4 0 |u http://dx.doi.org/10.1007/s00270-017-1839-2  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s00270-017-1839-2  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180530 
993 |a Article 
994 |a 2018 
998 |g 1155192338  |a Huppert, Peter E.  |m 1155192338:Huppert, Peter E.  |d 50000  |e 50000PH1155192338  |k 0/50000/  |p 7  |y j 
998 |g 123910846  |a Radeleff, Boris  |m 123910846:Radeleff, Boris  |d 50000  |e 50000PR123910846  |k 0/50000/  |p 2 
998 |g 1068606568  |a Richter, Götz Martin  |m 1068606568:Richter, Götz Martin  |d 50000  |e 50000PR1068606568  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1575844621  |e 3010801955 
BIB |a Y 
SER |a journal 
JSO |a {"note":["First Online: 22 November 2017","Gesehen am 30.05.2018"],"relHost":[{"part":{"issue":"4","year":"2018","volume":"41","pages":"587-593","text":"41(2018), 4, Seite 587-593","extent":"7"},"id":{"eki":["253390451"],"zdb":["1458490-6"],"issn":["1432-086X"]},"origin":[{"dateIssuedDisp":"1978-","publisher":"Springer ; Springer","dateIssuedKey":"1978","publisherPlace":"Berlin ; Heidelberg ; New York, NY"}],"disp":"Safety and feasibility of chemoembolization with doxorubicin-loaded small Calibrated microspheres in patients with hepatocellular carcinoma results of the MIRACLE I prospective multicenter studyCardioVascular and interventional radiology","recId":"253390451","title":[{"title_sort":"CardioVascular and interventional radiology","subtitle":"CVIR","title":"CardioVascular and interventional radiology"}],"pubHistory":["1.1978 -"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 27. November 2017","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 20.1997: Supplement"],"titleAlt":[{"title":"CVIR"},{"title":"Cardiovascular radiology"},{"title":"CardioVascular & interventional radiology"}]}],"person":[{"display":"Richter, Götz Martin","role":"aut","given":"Götz Martin","family":"Richter"},{"display":"Radeleff, Boris","role":"aut","given":"Boris","family":"Radeleff"},{"display":"Stroszczynski, Christian","role":"aut","given":"Christian","family":"Stroszczynski"},{"family":"Pereira","role":"aut","given":"Philippe L.","display":"Pereira, Philippe L."},{"given":"Thomas","role":"aut","family":"Helmberger","display":"Helmberger, Thomas"},{"given":"Mark","role":"aut","family":"Barakat","display":"Barakat, Mark"},{"family":"Huppert","given":"Peter E.","role":"aut","display":"Huppert, Peter E."}],"title":[{"title":"Safety and feasibility of chemoembolization with doxorubicin-loaded small Calibrated microspheres in patients with hepatocellular carcinoma","subtitle":"results of the MIRACLE I prospective multicenter study","title_sort":"Safety and feasibility of chemoembolization with doxorubicin-loaded small Calibrated microspheres in patients with hepatocellular carcinoma"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"7 S."}],"language":["eng"],"id":{"eki":["1575844621"],"doi":["10.1007/s00270-017-1839-2"]},"origin":[{"dateIssuedDisp":"2018","dateIssuedKey":"2018"}],"name":{"displayForm":["Götz Richter, Boris Radeleff, Christian Stroszczynski, Philippe Pereira, Thomas Helmberger, Mark Barakat, Peter Huppert"]},"recId":"1575844621"} 
SRT |a RICHTERGOESAFETYANDF2018